By Melissa Patrick
Kentucky Health News
FRANKFORT, Ky. -- A bill to limit cost-sharing requirements for insulin has passed the state House and gone to the Senate.
"I'm sure with the bipartisan support over here and the governor's support, we'll have a lot of support over there too," the bill's sponsor, Rep. Danny Bentley, said after the House passed it without dissent Feb. 19.
Gov. Andy Beshear endorsed the bill, which has a total of 74 sponsors, at a news conference, held at the Capitol the day before the House vote.
“Health care is a human right, but tragically right now there are far too many Kentuckians who are at risk of losing their life or permanently damaging their health because they cannot afford their daily supply of insulin,” said Beshear. “This is unacceptable and dangerous and lawmakers can act by immediately passing legislation to help thousands of fellow Kentuckians. Let’s let Kentucky be one of the first to act. We need to cap insulin costs because it’s the right thing to do.”
While many states are considering legislation to cap monthly insulin costs, so far only two have passed such a law: Colorado and Illinois.
House Bill 12 would require state-regulated health-insurance plans to cap a patient's cost for a 30-day supply of each insulin prescription drug at $100 "regardless of the amount or type of insulin needed to meet the covered person's insulin needs." The bill does not include Medicaid, Medicare or self-insured government plans.
The bill passed with a committee substitute and a House floor amendment to ensure that an insurer cannot increase its cost sharing requirements if its current requirement is less than $100 for a 30-day supply of insulin.
Insulin is a hormone that regulates the amount of glucose in the blood, and a lack of it causes diabetes. People with Type I diabetes can't make any insulin so they must inject it to control their blood sugar -- and to stay alive. People with Type II diabetes, which is more common, can produce some insulin, but not enough. Type II is usually treated with diet, exercise and oral medications.
Bentley said more than 500,000 Kentuckians have diabetes, which amounts to about one in eight, and about 50,000 more either have pre-diabetic or have diabetes, but have never been diagnosed. He said diabetes is costing the state upwards of $6 billion a year in healthcare costs.
Bentley explained that in the last 14 years, the cost of insulin has gone up 550 percent and that this has resulted in some diabetics rationing their supply or skipping doses, which can lead to severe health problems or even death.
"This is actually needed for survival," he said.
Rep. Charles Booker, who has Type I diabetes, said with emotion that he was voting yes on this bill for his daughters and for his mother, who sometimes didn't even have $100 to buy his insulin, which he needed to stay alive.
"This bill is an important step forward, making sure that Kentuckians can live a gainful life no matter the ZIP code or how much money they have in their pocket," Booker said. "It's not a partisan thing. It's something that we all should be fighting for."
Rep. Patti Minter, D-Bowling Green, whose son has Type I diabetes, cautioned that this bill doesn't go far enough.
"This bill does not do everything that many of us want done," she said. "We have work to do to have insulin for all, but this is an excellent start."
Bentley, who is a pharmacist with Type I diabetes, told the House Health and Family Services Committee on Feb. 13 that this bill is supported by the American Association of Retired Persons, the American Diabetes Association, the Kentucky Medical Association, the Kentucky Pharmacy Association and Insulin4All.
If passed into law, it would take effect Jan. 1, 2021.
Kentucky Health News
FRANKFORT, Ky. -- A bill to limit cost-sharing requirements for insulin has passed the state House and gone to the Senate.
 |
| Rep. Danny Bentley presents bill to cap the co-pay for 30-day supply of insulin to $100 per month. (Photo by Melissa Patrick) |
Gov. Andy Beshear endorsed the bill, which has a total of 74 sponsors, at a news conference, held at the Capitol the day before the House vote.
“Health care is a human right, but tragically right now there are far too many Kentuckians who are at risk of losing their life or permanently damaging their health because they cannot afford their daily supply of insulin,” said Beshear. “This is unacceptable and dangerous and lawmakers can act by immediately passing legislation to help thousands of fellow Kentuckians. Let’s let Kentucky be one of the first to act. We need to cap insulin costs because it’s the right thing to do.”
While many states are considering legislation to cap monthly insulin costs, so far only two have passed such a law: Colorado and Illinois.
House Bill 12 would require state-regulated health-insurance plans to cap a patient's cost for a 30-day supply of each insulin prescription drug at $100 "regardless of the amount or type of insulin needed to meet the covered person's insulin needs." The bill does not include Medicaid, Medicare or self-insured government plans.
The bill passed with a committee substitute and a House floor amendment to ensure that an insurer cannot increase its cost sharing requirements if its current requirement is less than $100 for a 30-day supply of insulin.
Insulin is a hormone that regulates the amount of glucose in the blood, and a lack of it causes diabetes. People with Type I diabetes can't make any insulin so they must inject it to control their blood sugar -- and to stay alive. People with Type II diabetes, which is more common, can produce some insulin, but not enough. Type II is usually treated with diet, exercise and oral medications.
Bentley said more than 500,000 Kentuckians have diabetes, which amounts to about one in eight, and about 50,000 more either have pre-diabetic or have diabetes, but have never been diagnosed. He said diabetes is costing the state upwards of $6 billion a year in healthcare costs.
Bentley explained that in the last 14 years, the cost of insulin has gone up 550 percent and that this has resulted in some diabetics rationing their supply or skipping doses, which can lead to severe health problems or even death.
"This is actually needed for survival," he said.
Rep. Charles Booker, who has Type I diabetes, said with emotion that he was voting yes on this bill for his daughters and for his mother, who sometimes didn't even have $100 to buy his insulin, which he needed to stay alive.
"This bill is an important step forward, making sure that Kentuckians can live a gainful life no matter the ZIP code or how much money they have in their pocket," Booker said. "It's not a partisan thing. It's something that we all should be fighting for."
Rep. Patti Minter, D-Bowling Green, whose son has Type I diabetes, cautioned that this bill doesn't go far enough.
"This bill does not do everything that many of us want done," she said. "We have work to do to have insulin for all, but this is an excellent start."
Bentley, who is a pharmacist with Type I diabetes, told the House Health and Family Services Committee on Feb. 13 that this bill is supported by the American Association of Retired Persons, the American Diabetes Association, the Kentucky Medical Association, the Kentucky Pharmacy Association and Insulin4All.
If passed into law, it would take effect Jan. 1, 2021.
from KENTUCKY HEALTH NEWS https://ift.tt/2Vb6al7
0 Response to "Bill to cap the price of insulin for some to $100 per prescription for a 30-day supply passes House, now moves to Senate-HEALTHYLIVE"
Post a Comment